News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
39,458 Results
Type
Article (2760)
Company Profile (39)
Press Release (36656)
Multimedia
Podcasts (8)
Webinars (2)
Section
Business (14226)
Career Advice (79)
Deals (2109)
Drug Delivery (10)
Drug Development (4288)
Employer Resources (10)
FDA (588)
Job Trends (788)
News (20525)
Policy (1168)
Tag
Academia (146)
Accelerated approval (3)
Adcomms (1)
Allergies (7)
Alliances (3503)
ALS (4)
Alzheimer's disease (57)
Antibody-drug conjugate (ADC) (23)
Approvals (575)
Artificial intelligence (18)
Autoimmune disease (3)
Automation (1)
Bankruptcy (12)
Best Places to Work (490)
BIOSECURE Act (2)
Biosimilars (18)
Biotechnology (29)
Bladder cancer (8)
Brain cancer (8)
Breast cancer (30)
Cancer (228)
Cardiovascular disease (10)
Career advice (65)
Career pathing (1)
CAR-T (24)
CDC (1)
Cell therapy (66)
Cervical cancer (2)
Clinical research (3370)
Collaboration (133)
Company closure (2)
Compensation (72)
Complete response letters (1)
COVID-19 (209)
CRISPR (10)
C-suite (50)
Cystic fibrosis (5)
Data (209)
Denatured (5)
Depression (8)
Diabetes (16)
Diagnostics (473)
Digital health (1)
Diversity (1)
Diversity, equity & inclusion (1)
Drug discovery (19)
Drug pricing (11)
Drug shortages (1)
Duchenne muscular dystrophy (26)
Earnings (4414)
Editorial (8)
Employer branding (1)
Employer resources (8)
Events (6204)
Executive appointments (119)
FDA (670)
Funding (108)
Gene editing (21)
Gene therapy (35)
GLP-1 (72)
Government (210)
Guidances (21)
Healthcare (719)
HIV (1)
Huntington's disease (4)
IgA nephropathy (8)
Immunology and inflammation (25)
Immuno-oncology (4)
Indications (3)
Infectious disease (218)
Inflammatory bowel disease (14)
Inflation Reduction Act (7)
Influenza (9)
Intellectual property (14)
Interviews (7)
IPO (1002)
IRA (8)
Job creations (291)
Job search strategy (63)
Kidney cancer (6)
Labor market (8)
Layoffs (48)
Leadership (1)
Legal (217)
Liver cancer (8)
Longevity (1)
Lung cancer (21)
Lymphoma (8)
Management (4)
Manufacturing (31)
MASH (6)
Medical device (320)
Medtech (320)
Mergers & acquisitions (1205)
Metabolic disorders (49)
Multiple sclerosis (13)
NASH (2)
Neurodegenerative disease (19)
Neuropsychiatric disorders (5)
Neuroscience (129)
NextGen: Class of 2025 (356)
Non-profit (154)
Now hiring (7)
Obesity (24)
Opinion (17)
Ovarian cancer (14)
Pain (17)
Pancreatic cancer (13)
Parkinson's disease (7)
Partnered (2)
Patents (37)
Patient recruitment (8)
Peanut (1)
People (5755)
Pharmaceutical (5)
Phase I (1442)
Phase II (1671)
Phase III (933)
Pipeline (173)
Policy (16)
Postmarket research (32)
Preclinical (621)
Press Release (2)
Prostate cancer (5)
Psychedelics (2)
Radiopharmaceuticals (13)
Rare diseases (40)
Real estate (423)
Recruiting (5)
Regulatory (947)
Reports (7)
Research institute (146)
Resumes & cover letters (9)
RNA editing (5)
RSV (1)
Schizophrenia (15)
Series A (33)
Series B (12)
Service/supplier (2)
Sickle cell disease (3)
Special edition (4)
Spinal muscular atrophy (3)
Sponsored (1)
Startups (497)
Stomach cancer (2)
Supply chain (4)
The Weekly (2)
Vaccines (53)
Venture capital (10)
Weight loss (17)
Women's health (4)
Worklife (1)
Date
Today (14)
Last 7 days (54)
Last 30 days (217)
Last 365 days (2496)
2025 (1621)
2024 (2647)
2023 (2904)
2022 (3791)
2021 (4118)
2020 (3531)
2019 (2091)
2018 (1573)
2017 (1805)
2016 (1639)
2015 (1844)
2014 (1375)
2013 (1193)
2012 (1401)
2011 (1336)
2010 (1187)
Location
Africa (44)
Alabama (2)
Arizona (16)
Asia (1938)
Australia (305)
California (1190)
Canada (185)
China (50)
Colorado (29)
Connecticut (12)
Delaware (4)
Europe (3965)
Florida (51)
Georgia (11)
Hawaii (2)
Idaho (3)
Illinois (17)
India (1)
Indiana (39)
Japan (12)
Kansas (12)
Kentucky (1)
Maryland (34)
Massachusetts (418)
Michigan (12)
Minnesota (18)
Mississippi (1)
Missouri (4)
Nebraska (1)
Nevada (3)
New Hampshire (2)
New Jersey (96)
New York (61)
North Carolina (106)
Northern California (531)
Ohio (30)
Oklahoma (2)
Oregon (5)
Pennsylvania (75)
Rhode Island (2)
South America (40)
South Carolina (1)
Southern California (495)
Tennessee (3)
Texas (106)
United States (2383)
Utah (3)
Virginia (7)
Washington D.C. (1)
Washington State (69)
West Virginia (1)
Wisconsin (7)
39,458 Results for "greenlight biosciences".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Brain cancer
FDA Greenlights Jazz’s Dordaviprone, First New Treatment for Ultra-Rare Brain Tumor
The small molecule drug, acquired by Jazz Pharmaceuticals in its $935 million Chimerix pick-up this spring, is intended for relapsed adult and pediatric patients with H3 K27M mutations.
August 6, 2025
·
2 min read
·
Dan Samorodnitsky
FDA
2024 Ends With Greenlights for Merck’s PAH Drug in UK and BMS’ Opdivo Injection in US
Regulators squeezed in two final approvals before the calendar change with the UK approval of Merck’s Winrevair and the FDA’s greenlight for an injectable formulation of BMS’s cancer blockbuster.
January 2, 2025
·
2 min read
·
Kate Goodwin
Genetown
GreenLight Biosciences Secures EPA Registration for New Bioinsecticide, Calantha, Historic Step Towards A Safer and More Sustainable Food System
GreenLight Biosciences (GreenLight Bio) has been granted registration by the U.S. Environmental Protection Agency (EPA) and several states for its groundbreaking Calantha™ product, designed to target and control the highly destructive Colorado potato beetle.
January 4, 2024
·
5 min read
Deals
GreenLight Biosciences Announces Expiration of Tender Offer Period for Outstanding Shares
GreenLight Biosciences Holdings, PBC (NASDAQ: GRNA) (“GreenLight” or the “Company”) today announced that it is initiating the final steps in closing its previously announced merger with SW MergerCo, Inc. (“Merger Sub”) and SW ParentCo, Inc (“Parent”).
July 20, 2023
·
6 min read
Deals
GreenLight Announces Completion of Merger with Fall Line Endurance Fund
GreenLight Biosciences Holdings, PBC announced the closing of its previously announced merger with SW MergerCo, Inc. and SW ParentCo, Inc., pursuant to which Merger Sub merged with and into GreenLight with GreenLight surviving as a wholly-owned subsidiary of Parent.
July 24, 2023
·
5 min read
Genetown
GreenLight Biosciences Releases Inaugural Sustainability Report
GreenLight Biosciences (Nasdaq: GRNA), a public benefit corporation striving to deliver on the full potential of RNA to address some of the world’s toughest problems in human health and agriculture, today released its inaugural Sustainability Report.
April 12, 2023
·
6 min read
Business
GreenLight Biosciences Announces First Quarter 2023 Financial Results and Highlights Recent Company Progress
GreenLight Biosciences, PBC, a biotechnology company dedicated to making RNA products affordable and accessible for human health and agriculture, reported operational highlights and financial results for the first quarter ended March 31, 2023.
May 11, 2023
·
10 min read
Genetown
GreenLight Biosciences Holdings Confirms Receipt of Indication of Interest from Fall Line
GreenLight Biosciences confirmed that it has received a non-binding indication of interest from Fall Line Endurance Fund, L.P. to acquire all of the outstanding capital stock of the Company for $0.60 per share in cash.
March 30, 2023
·
6 min read
Collaboration
Eli Lilly Commits $856M in Biobucks to Gate Bioscience for New Class of Medicines
The collaboration focuses on ‘molecular gates,’ a class of molecules that the startup company Gate Bioscience says can stop pathogenic proteins from leaving the cell.
July 25, 2025
·
1 min read
·
Dan Samorodnitsky
Genetown
GreenLight Biosciences announces $109 million financing
GreenLight Biosciences today announced a private placement of approximately $109 million.
August 12, 2022
·
5 min read
1 of 3,946
Next
